Back
Onco-Innovations Ltd (ONNVF) Earnings
ONNVF Stock Price Chart
ONNVF Earnings
Onco-Innovations Ltd
$0.51
4.1%
$0.02
At close: Mar 30, 16:00:00 GMT-4
$0.51
0%
$0
Post-market: Mar 30, 19:22:53 GMT-4
No Data YetEarnings FAQ
¿Cómo se comparó el EPS reciente de ONNVF con las expectativas?
¿Cómo fue el desempeño de los ingresos de Onco-Innovations Ltd ONNVF en el último trimestre?
¿Cuál es la estimación de ingresos para Onco-Innovations Ltd?
¿Cuál es la puntuación de calidad de ganancias de Onco-Innovations Ltd?
¿Cuándo informa Onco-Innovations Ltd sus ganancias?
¿Cuáles son las ganancias esperadas de Onco-Innovations Ltd?
¿Superó Onco-Innovations Ltd las expectativas de ganancias?
Key Stats
Prev.Close
$0.4949
Open
$0.5152
Day's Range
$0.5152 - $0.5152
52 week range
$0.4287 - $3.2
Volume
500
Avg.Volume
3.6K
Dividend yield
--
EPS (TTM)
--
Market Cap
--
What is ONNVF?
Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. The company is headquartered in Calgary, Alberta. The company went IPO on 2024-11-27. The firm holds an exclusive worldwide license to patented technology that targets solid tumors. The firm is engaged in developing and commercializing treatments for various types of cancer. Its solution focuses on targeting cancer cells, effectively eliminating them and preventing their regrowth. Its licensed technology focuses on Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors. Its SynoGraph platform merges genomic, proteomic, and multimodal datasets to uncover deep insights into disease mechanisms, potentially enabling more personalized and effective treatment strategies.
Features
Resources
© 2026 Finture Development Limited. All rights reserved